Core Scientific Inc vs Kyndryl Holdings Inc — how do they compare? Core Scientific Inc trades at $15.62 (market cap $4.94B), while Kyndryl Holdings Inc trades at $11.95 (market cap $2.59B). The key difference: Core Scientific Inc is the larger of the two by market cap, and Core Scientific Inc is more actively traded (15,630,800 versus 5,354,348). Which is the better fit depends on your goals — on Pluang, investors hold Core Scientific Inc for 20 Days and Kyndryl Holdings Inc for 36 Days on average.
| CORZ | KD | |
|---|---|---|
Market Cap | $4.94B | $2.59B |
Volume | 15,630,800 | 5,354,348 |
Sector | Technology | Technology |
52-Week High | $29.16 | $29.76 |
52-Week Low | $13.57 | $10.59 |
Typical Hold Time | 20 Days | 36 Days |
Enterprise Value | $7.46B | $5.41B |
Signals from Pluang's Aura AI — not financial advice
CORZ trades at $15.94, down 4.44% on the day, with a bearish technical signal from moving averages. The company reported a net loss of $288.62 million in 2025, with a negative net income margin of -324.9% in 2026. Recent news highlights its pivot to AI data center hosting and executive appointments, while analyst consensus remains strongly bullish with an 86.36% buy rating.
The outlook is mixed: strong analyst support and AI infrastructure growth offer upside potential, but persistent losses, high cash burn, and competitive pressures pose significant risks. Investors face volatility from execution challenges in the capital-intensive data center transition.
Kyndryl Holdings (KD) trades at $11.45, down 0.26% on the day, with technical indicators showing bearish momentum. The company reported mixed quarterly results, missing Q4 2025 and Q1 2026 EPS estimates but beating in Q2 2026. Recent financials show improved profitability with 2025 net income of $252 million, though revenue has declined from $18.3B in 2022 to $15.1B in 2025. Analyst sentiment is cautious with a consensus 'Hold' rating and $14.67 price target, while institutional activity includes recent purchases by Virginia Retirement Systems.
KD presents a turnaround story with improving profitability but faces revenue headwinds and competitive pressures. The stock trades at reasonable valuation multiples (P/E 30.95, P/S 0.18) with positive cash flow generation. Key risks include ongoing revenue declines and high debt levels, while opportunities exist in AI initiatives and government contracts. The current technical weakness may present entry points for patient investors betting on management's execution.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Core Scientific provides digital infrastructure for Bitcoin mining and high-performance computing (HPC). It operates purpose-built data centers to support digital asset production and AI-related workloads.
Read more on CORZ →Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives.
Read more on KD →